Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL375872 | 0.82 | THRB (0.40) | THRBLMNA | |
| SCHEMBL2552956 | 0.82 | THRB (0.40) | THRBLMNA | |
| SCHEMBL56349 | 0.76 | THRB (0.48) | THRBLMNA | |
| SCHEMBL15735992 | 0.73 | THRB (0.32) | THRB | |
| SCHEMBL56737 | 0.72 | THRB (0.43) | THRBLMNA | |
| SCHEMBL734469 | 0.71 | LMNA (0.35) | THRBLMNA | |
| SCHEMBL29289473 | 0.71 | THRB (0.53) | THRBLMNA | |
| SCHEMBL6064040 | 0.71 | THRB (0.53) | THRBLMNA | |
| SCHEMBL55867 | 0.69 | THRB (0.40) | THRB | |
| SCHEMBL15733711 | 0.68 | THRB (0.34) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138365-B2 | Method for producing organosilanes | EVONIK DEGUSSA GMBH (DE) | 2012-03-20 | — | — | US | claimed |
| US-20100217026-A1 | Method for producing organosilanes | EVONIK OPERATIONS GMBH (DE) | 2010-08-26 | — | — | US | claimed |
| EP-2057172-B1 | METHOD FOR PRODUCING ORGANOSILANES | EVONIK DEGUSSA GMBH (DE) | 2013-09-11 | — | — | EP | disclosed |
| US-8138365-B2 | Method for producing organosilanes | EVONIK DEGUSSA GMBH (DE) | 2012-03-20 | — | — | US | disclosed |
| US-20100217026-A1 | Method for producing organosilanes | EVONIK OPERATIONS GMBH (DE) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100217026-A1 | Method for producing organosilanes | TST, STS, HAO2 | THRB 2259/4885LMNA 4751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.